Old Web
English
Sign In
Acemap
>
authorDetail
>
S. Nuthalapati
S. Nuthalapati
Veliparib
Stage III NSCLC
Oncology
Paclitaxel carboplatin
Pathology
3
Papers
3
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
PK/PD model prediction of platelet reduction to guide phase III dose selection for navitoclax added on to ruxolitinib in myelofibrosis
2021
S. Nuthalapati
Leanne Holes
Josef T. Prchal
Christine J. Harrison
Tim C.P. Somervaille
J Hayslip
J. Potluri
R. Menon
S Mensing
Show All
Source
Cite
Save
Citations (0)
MA 17.07 Veliparib in Combination with Paclitaxel/Carboplatin (P/C)-Based Chemoradiotherapy (CRT) in Patients with Stage III NSCLC
2017
Journal of Thoracic Oncology
T. Stinchcombe
David Kozono
Joseph K. Salama
J.A. Bogart
William J. Petty
Michael J. Guarino
Lyudmila Bazhenova
James M. Larner
Jared Weiss
Thomas A. DiPetrillo
Steven J. Feigenberg
Tu Xu
Beibei Hu
S. Nuthalapati
Lindsey Rosenwinkel
Lindsey Bensman
E. Johnson
Mark D. McKee
Everett E. Vokes
Show All
Source
Cite
Save
Citations (1)
Self healing reconfiguration for restoration of naval shipboard power systems
2004
PSCE | IEEE PES Power Systems Conference and Exposition
Karen L. Butler-Purry
S. Nuthalapati
Show All
Source
Cite
Save
Citations (2)
1